Only 0.3–1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment. We report a case of ALK-1–negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.

Inflammatory myofibroblastic tumour of the larynx: report of a case / Colizza, Andrea; Meliante, PIERO GIUSEPPE; Donsante, Samantha; Riminucci, Mara; Greco, Antonio; DE VINCENTIIS, Marco; Corsi, Alessandro. - In: EAR, NOSE & THROAT JOURNAL. - ISSN 0145-5613. - (2022), p. 014556132211010. [10.1177/01455613221101087]

Inflammatory myofibroblastic tumour of the larynx: report of a case

Andrea Colizza
Primo
;
Piero Giuseppe Meliante
Secondo
;
Samantha Donsante;Mara Riminucci;Antonio Greco;Marco De Vincentiis
Penultimo
;
Alessandro Corsi
Ultimo
2022

Abstract

Only 0.3–1% of laryngeal cancer are non-squamous cell neoplasms. Of these, a rare entity is inflammatory myofibroblastic tumour (IMT), in which anaplastic lymphoma kinase-1 (ALK-1) is frequently expressed. Just 50 cases of IMT have been reported. Therefore, many otolaryngologists may be unfamiliar with this type of tumour and be prone to its over- or undertreatment. We report a case of ALK-1–negative IMT treated with transoral endoscopic excision and disease-free 6 months after surgery.
2022
larynx; laryngeal neoplasms; inflammatory myofibroblastic tumour; transoral surgery
01 Pubblicazione su rivista::01i Case report
Inflammatory myofibroblastic tumour of the larynx: report of a case / Colizza, Andrea; Meliante, PIERO GIUSEPPE; Donsante, Samantha; Riminucci, Mara; Greco, Antonio; DE VINCENTIIS, Marco; Corsi, Alessandro. - In: EAR, NOSE & THROAT JOURNAL. - ISSN 0145-5613. - (2022), p. 014556132211010. [10.1177/01455613221101087]
File allegati a questo prodotto
File Dimensione Formato  
Colizza_Inflammatory myofibroblastic tumour_2022.pdf

accesso aperto

Note: https://journals.sagepub.com/doi/full/10.1177/01455613221101087
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.3 MB
Formato Adobe PDF
1.3 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1632041
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact